Connect with us

Health & Fitness

FDA Curbs Use of COVID-19 Convalescent Plasma, Citing New Data

Only high-titer COVID-19 convalescent plasma can be used, and only in hospitalized patients early in the disease course or for patients with impaired immune function. News Alerts

Published

on

FDA Curbs Use of COVID-19 Convalescent Plasma, Citing New Data